ArticleCPT: pharmacometrics & systems pharmacology2025

Using Pharmacokinetic and Pharmacodynamic Analysis to Optimize the Dosing Regimens of Fanastomig (EMB-02) in Patients With Advanced Solid Tumors.

Chengjun Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.